Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1981
Report date:
1981

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
no
Remarks:
study performed before implementation of GLP
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Ethyl 2-ethylhexanoate
EC Number:
221-043-3
EC Name:
Ethyl 2-ethylhexanoate
Cas Number:
2983-37-1
Molecular formula:
C10H20O2
IUPAC Name:
ethyl 2-ethylhexanoate
Details on test material:
- Name of test material (as cited in study report): 2-ethyl-ethyl-capronat
- Analytical purity: no data

Test animals

Species:
mouse
Strain:
CF-1
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: young adult
- Weight at study initiation: approx. 24 g
- Fasting period before study: yes
- Housing: no data
- Diet (e.g. ad libitum): Altromin maintainance diet, Nr. 1324
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 d

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): approx. 50%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 79 - 315 g/L
- Purity: 2% CMC/MED/Type 70

MAXIMUM DOSE VOLUME APPLIED: 20 cm³/kg bw for all dose levels

Doses:
1680, 1990, 3160, 3980, 5010, 5600, 6310 mg/kg bw
No. of animals per sex per dose:
10
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: day 0 (prior to administration); after 48 h, 1 week, 2 weeks
- Necropsy of survivors performed: only 3-6 animals per dose group were examined after necropsy
Statistics:
Litchfield and Wilcoxon (J. Pharm. exptl. ther. 96, 99 - 108 (1949))

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
LD50
Effect level:
4 450 mg/kg bw
Based on:
act. ingr.
95% CL:
>= 3 800 - <= 5 210
Mortality:
1680 mg/kg bw: 0/10 animals died;
1990 mg/kg bw: 1/10 animals died;
3160 mg/kg bw: 3/10 animals died;
3980 mg/kg bw:4/10 animals died;
5010 mg/kg bw: 5/10 animals died;
5600 mg/kg bw: 7/10 animals died;
6310 mg/kg bw: 10/10 animals died
Clinical signs:
reduced breathing frequency, reduced activity, abnormal posture
Body weight:
body weight gain of surviving animals was similar in all dose groups
Gross pathology:
no findings in examined animals

Applicant's summary and conclusion

Interpretation of results:
other: not classified according to CLP regulation
Conclusions:
Based on the results obtained after a single oral administration to male mice, the oral LD50 of 2-Ethyl ethyl capronate was determined to be 4450 mg/kg bw.
Executive summary:

In an acute oral toxicity study similar to OECD guideline 401, groups of 10 fasted male CF-1 mice were given a single oral dose of 2-Ethyl ethyl capronate at doses of 1680, 1990, 3160, 3980, 5010, 5600 and 6310 mg/kg bw and observed for 14 days.

The following mortality was observed: 0/10 at 1680 mg/kg bw; 1/10 at 1990 mg/kg bw; 3/10 at 3160 mg/kg bw; 4/10 at 3980 mg/kg bw; 5/10 at 5010 mg/kg bw; 7/10 at 5600 mg/kg bw; 10/10 at 6310 mg/kg bw.

The surviving animals showed reduced activity after 2 and 24 h, reduced breathing frequency after 2 h and abnormal posture after 2 h.

No changes in body weight gain were observed in the surviving animals throughout all dose groups.

The oral LD50 was determined to be 4450 mg/kg bw (95% c.i. 3800 – 5210 mg/kg bw).